This session at Cell & Gene Therapy World Conference 2025 will highlight advances in ex vivo gene editing, focusing on techniques like CRISPR-Cas9 and their applications in treating genetic disorders and cancers. Key discussions will address challenges in precision, scalability, and accessibility, aiming to advance safe and equitable therapies for patients globally.